Standout Papers

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disea... 2014 2026 2018 2022 333
  1. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease (2014)
    Larysa Fedchuk, Fabio Nascimbeni et al. Alimentary Pharmacology & Therapeutics

Immediate Impact

2 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
2024 Standout
16 intermediate papers

Works of R. Pais being referenced

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
2014 Standout

Author Peers

Author Last Decade Papers Cites
R. Pais 336 172 47 165 3 353
Maria Rosa Barcellona 281 105 63 148 6 310
Ruth Sargent 261 114 21 164 6 301
Nzali V. Campbell 321 81 68 210 4 362
L Franzén 310 150 39 110 6 394
G.M. Pendino 246 163 55 71 5 303
Diamond Joy 314 125 68 142 8 394
Tracy Le 320 218 32 80 4 334
Jen Jung Pan 212 107 30 103 6 337
Kusano Yoshimasa 270 77 39 193 2 317
S. Genise 284 72 23 207 4 349

All Works

Loading papers...

Rankless by CCL
2026